Viewing nowTelmisartan 40mg Tablet
Telmisartan 40mg
Tablet · Prescription medication
Hallym Pharmaceutical Co., Ltd.

MFDS item code 201804853 · Approved 2018.11.30 · Insurance code 645305970
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
This medication is primarily used for the treatment of essential hypertension. It also helps reduce the risk of cardiovascular disease in high-risk patients aged 55 and older who cannot take ACE inhibitors, such as those with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage in diabetic patients. This can reduce mortality due to myocardial infarction, stroke, and cardiovascular disease. Therefore, this medication is effectively used not only for blood pressure control but also for cardiovascular protection.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended at a dose of 80 mg orally once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment; the dose should not exceed 40 mg once daily.
This medication can cause serious harm or death to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Those with hypersensitivity to this medication or its components, pregnant or potentially pregnant women, nursing mothers, individuals with severe liver impairment, hereditary angioedema patients, and patients with diabetes or moderate to severe kidney impairment should not take this medication. Elderly patients, those with hyperkalemia, patients with mild to moderate liver impairment, patients with heart valve disease or ischemic heart disease, those with gastrointestinal diseases, patients with renovascular hypertension, and those with severe kidney impairment should take this medication cautiously, with dose adjustments and monitoring of conditions as necessary. While taking this medication, blood pressure, kidney function, and electrolyte levels should be checked regularly, and especially due to the risks of hyperkalemia and renal function impairment, if any unusual symptoms appear, consult medical professionals immediately. This medication lowers blood pressure, which can lead to symptoms such as hypotension, syncope, and dizziness. If these symptoms occur, lie down and rest immediately and visit a hospital if needed. Also, angioedema may occur, so if swelling occurs in the face, lips, tongue, or you experience difficulty breathing, discontinue use immediately and seek emergency treatment. This medication may have interactions when used in combination with other antihypertensive drugs, so be sure to inform your healthcare provider of any medications you are taking. It is advisable to stop taking this medication at least 24 hours before surgery, and caution is required while driving or operating machinery due to the risk of dizziness or fainting. This medication contains sorbitol, thus those with hereditary fructose intolerance should avoid it, and its safety and efficacy in children and adolescents under 18 years have not been established, so it is not recommended. In case of overdose, symptoms such as hypotension, tachycardia, dizziness, and renal failure may appear, and immediate medical treatment should be sought. This medication should be kept out of the reach of children and transferring it to other containers is not advisable for maintaining quality and safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should remain at room temperature between 1°C and 30°C. This will help maintain the medication's efficacy and safety for a long time.
White or almost white, biconvex, round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Hallym Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.